BioMarin Pharmaceutical Inc. ( BMRN) TD Cowen 46th Annual Health Care Conference March 4, 2026 10:30 AM EST ...

X4 Pharmaceuticals is a BUY, driven by a funded Phase 3 trial, current product pipeline, and a strong cash position extending ...

As the pharmaceutical industry continues to evolve in the wake of pandemic-driven disruptions and heightened regulatory scrutiny, the role of the top pharmaceutical API manufacturer has taken on ...

The third quarter was a pivotal period for both the biotech and pharmaceutical sectors, with regulatory developments and an increase in business deals shaping the landscape for the industries. Public ...

Investing.com - Oppenheimer在 Catalyst Pharmaceutical Partners (纳斯达克股票代码:CPRX)公布第四季度业绩后,重申了跑赢大盘评级和33.00美元的目标价。 Catalyst ...

Biotech company BioMarin Pharmaceutical (NASDAQ:BMRN) reported Q4 CY2025 results , with sales up 17% year on year to $874.6 ...

TNF new strategic partner LightSolver named a 2025 World Economic Forum Technology Pioneer and recognized in Gartner’s 2025 Hype Cycle for Data Center Infrastructure Technologies LAS VEGAS--(BUSINESS ...

Collegium Pharmaceutical Inc.将于周四美股开盘前公布第四季度财报,投资者关注的焦点是这家特种制药公司能否在其ADHD (注意力缺陷多动障碍)产品线保持增长势头,同时保护其疼痛治疗产品组合免受仿制药竞争的冲击。

In recent years, the pharmaceutical landscape has witnessed a seismic shift as cannabinoids transition from niche alternatives to mainstream medical solutions. The days of skepticism surrounding ...

Two weeks ago, President Trump sent letters to 17 leading pharmaceutical manufacturers, giving them 60 days to propose plans to lower U.S. drug prices to align with the lowest prices offered in other ...

As pharmaceuticals were granted Most Favored Nation (MFN) treatment in the Korea-U.S. tariff negotiations, the domestic pharmaceutical and biotech industries have shown signs of relief. In particular, ...

Atrash also stressed the "pivotal" role of the Jordan Food and Drug Administration (JFDA) in supporting the sector, ...